Takeda Pharmaceutical Co ADR (NYSE:TAK) currently has a daily average trading volume of 2.08M but it saw 1980770 shares traded in last market. With a market cap of 45.35B USD, the company’s current market price of $14.41 came rising about 0.63 while comparing to the previous closing price of $14.32. In past 52 weeks, the stock remained buoying in the range of price level as high as $15.43 and as low as $12.57.
BofA Securities upgraded its recommendation for the stock as a “Buy” from “Neutral” on March 16, 2023 while assigning a price target of $20. Cowen also issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $21 and $24.
Over the week, TAK’s stock price is moving 2.93% up while it is -5.07% when we observe its performance for the past one month. Year-to-date it is 8.84% up and over the past year, the stock is showing an upside performance of 8.51%.
Currently, Takeda Pharmaceutical Co ADR’s total number of outstanding shares is 3.15B with 0.01% of that held by the insiders while 2.30% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 0.97% and return on equity (ROE) at 1.50%. It has a price to earnings ratio (P/E ratio) of 66.31 while having a 23.16 of forward P/E ratio. Stock’s beta reads 0.25. Stock has a price to book (P/B) ratio of 0.98 while price to sale or P/S ratio amounts to 1.51. Its return on asset (ROA) is 0.73% on average.
